Here are five things to know about the company’s de novo strategy: 1. USPI added nearly 70 ASCs in 2024, remaining “very active in both [mergers and acquisitions] and de novo development.” The company ...
Additionally, Becker’s reported on 26 cardiology-focused ASCs opened or announced in 2024. Here are five key takeaways from USPI’s cardiology strategy: 1. While USPI continues to prioritize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback